Shares of Nevro Corp. (NYSE:NVRO – Get Free Report) have earned a consensus rating of “Reduce” from the thirteen brokerages that are presently covering the firm, Marketbeat.com reports. Two investment ...

Spinal cord stimulators have grown in popularity over the past several years as patients see benefits in the less-invasive ...

Discover the top 3 undervalued Health Care Equipment & Supplies stocks for Wednesday, March 19 based on AAII’s Stock Grades.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Common causes of pain in the back of the head are different types of headaches, like tension, migraine, or exertion headaches. In some cases, pain in the back of the head can signal a more severe ...

Nevro Corp. (NYSE:NVRO – Get Free Report ... an evidence-based neuromodulation system for the treatment of chronic back and leg pain through paresthesia-free 10 kHz therapy, as well as offers ...

Could you really ease back pain, sciatica, or kidney stones by tipping backward on a table with your feet in the air? There’s some research to back up the value of inversion therapy for back ...

(AP) — Nevro Corp. (NVRO) on Tuesday reported a loss ... this ad The maker of an electrical implant that treats leg and back pain posted revenue of $105.5 million in the period, which also ...